Actively Recruiting
Risk Markers of Arterial Aging. The Paris Prospective Study III-2
Led by Institut National de la Santé Et de la Recherche Médicale, France · Updated on 2025-09-11
7500
Participants Needed
1
Research Sites
440 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.
CONDITIONS
Official Title
Risk Markers of Arterial Aging. The Paris Prospective Study III-2
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Being enrolled in PPS3 and having signed an informed consent for PPS3-2
You will not qualify if you...
- Institutionalized participants
- Participants under guardianship
- Participants under judicial safeguard measure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre d'Investigation Précliniques
Paris, France, 75016
Actively Recruiting
Research Team
J
Jean-Philippe Empana, MD, PhD
CONTACT
X
Xavier Jouven, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here